Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

11

Revenue 2017

AstraZeneca

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.

Astra Zeneca

Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels

Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels A mixed COVID-19 vaccination schedule, administering the AstraZeneca (AZ) vaccine as the first dose and the Pfizer/BioNTech jab as the second dose, boosts neutralising antibody levels six-fold compared ... first dose of the AstraZeneca/Oxford University

AZ’s PNH therapy Ultomiris wins EU backing to expand use for children

AZ’s PNH therapy Ultomiris wins EU backing to expand use for children AstraZeneca’s rare disease unit Alexion has gained a positive recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) to expand the use of

One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants

One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants New real-world data has demonstrated that one dose of AstraZeneca’s COVID-19 vaccine is ‘highly effective’ at reducing severe disease and hospitalisation caused by variants of concern after one

AZ licenses pneumonia mAb to Aridis Pharmaceuticals for $11m upfront

AZ licenses pneumonia mAb to Aridis Pharmaceuticals for $11m upfront AstraZeneca (AZ) has entered an exclusive license agreement with Aridis Pharmaceuticals for its late-stage monoclonal antibody (mAb) candidate suvratoxumab. ... We are pleased to have been selected as AstraZeneca's licensee. The strong data from the

FDA advisory committee votes against approval of AZ, FibroGen's roxadustat

FDA advisory committee votes against approval of AZ, FibroGen's roxadustat A US Food and Drug Administration (FDA) advisory committee has voted against approval of AstraZeneca (AZ) and FibroGen’s roxadustat for the treatment of anaemia in chronic kidney disease (CKD) patients.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....